Abstract
Introduction
Hip osteoarthritis (OA) is one of the leading causes of disability and morbidity worldwide. It is estimated to affect 9.2% individuals globally with age over 45 years. Conventional treatment modalities have limitations and side-effects. To overcome these limitations, over the last decade, there has been an increased interest in the use of orthobiologics derived from autologous sources including platelet-rich plasma (PRP), bone-marrow aspirate concentrate (BMAC) and adipose tissue derived formulations. This review qualitatively presents the in-vitro, pre-clinical, clinical and on-going clinical studies exploring the safety and efficacy of BMAC for management of hip OA.
Materials and methods
The electronic database search was done through PubMed, Embase, Web of Science, Scopus, ProQuest and Google Scholar till February 2024. The search terms used were “osteoarthritis” OR “hip osteoarthritis” OR “orthobiologics” OR “efficacy or use of orthobiologic treatment” OR “bone-marrow concentrate” OR “bone-marrow aspirate concentrate”, AND “BMAC”. The inclusion criteria were clinical studies of any level of evidence written in the English language, published till February 2024, evaluating the safety and efficacy of intra-articular administration of BMAC for the management of hip OA.
Results
A total of 5 studies were included in this review for qualitative data synthesis. The total number of patients who participated in the study was 182, ranging from 4 to 112 in a single study. No adverse events were reported throughout the duration of the study. In addition, intra-articular administration of BMAC led to reduced pain, and improved function and overall quality of life (QoL).
Conclusion
The results from this review demonstrated that administration of BMAC is safe and potentially efficacious in terms of reducing pain, improving function and overall QoL of patients with hip OA in short- and mid-term average follow-up based on the included studies. Nonetheless, more adequately powered, multi-center, prospective, double-blind, non-randomized and randomized controlled trials with long-term follow-up are warranted to establish long-term safety and efficacy of BMAC for management of hip OA and justify its routine clinical use.
Similar content being viewed by others
Data Availability
All data is contained within the manuscript.
References
Long, H., Liu, Q., Yin, H., Wang, K., Diao, N., Zhang, Y., et al. (2022). Prevalence trends of site-specific osteoarthritis from 1990 to 2019: Findings from the global burden of disease study 2019. Arthritis & Rheumatology, 74(7), 1172–1183.
Fan, Z., Yan, L., Liu, H., Li, X., Fan, K., Liu, Q., et al. (2023). The prevalence of hip osteoarthritis: A systematic review and meta-analysis. Arthritis Research & Therapy, 25(1), 51.
Turkiewicz, A., Petersson, I. F., Björk, J., Hawker, G., Dahlberg, L. E., Lohmander, L. S., et al. (2014). Current and future impact of osteoarthritis on health care: A population-based study with projections to year 2032. Osteoarthritis and cartilage, 22(11), 1826–1832.
Steinmetz, J. D., Culbreth, G. T., Haile, L. M., Rafferty, Q., Lo, J., Fukutaki, K. G., et al. (2023). Global, regional, and national burden of osteoarthritis, 1990–2020 and projections to 2050: A systematic analysis for the global burden of disease study 2021. The Lancet Rheumatology, 5(9), e508–e522. https://doi.org/10.1016/S2665-9913(23)00163-7
Neogi, T. (2013). The epidemiology and impact of pain in osteoarthritis. Osteoarthritis and cartilage, 21(9), 1145–1153.
Hunter, D. J., March, L., & Chew, M. (2020). Osteoarthritis in 2020 and beyond: A lancet commission. The Lancet, 396(10264), 1711–1712. https://doi.org/10.1016/S0140-6736(20)32230-3
Abbafati, C., Abbas, K. M., Abbasi-Kangevari, M., Abd-Allah, F., Abdelalim, A., Abdollahi, M., et al. (2020). Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the global burden of disease study 2019. The Lancet, 396(10258), 1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9
da Costa, B. R., Reichenbach, S., Keller, N., Nartey, L., Wandel, S., Jüni, P., et al. (2017). Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: A network meta-analysis. The Lancet, 390(10090), e21–e33. https://doi.org/10.1016/S0140-6736(17)31744-0
Leite, V. F., Daud, A. J. E., & Buehler, A. M. (2018). Viscosupplementation for hip osteoarthritis: A systematic review and meta-analysis of the efficacy on pain and disability, and the occurrence of adverse events. Archives of Physical Medicine and Rehabilitation, 99(3), 574–583. https://doi.org/10.1016/J.APMR.2017.07.010
Pereira, L. C., Kerr, J., & Jolles, B. M. (2016). Intra-articular steroid injection for osteoarthritis of the hip prior to total hip arthroplasty: Is it safe? A systematic review. The bone & joint journal, 98(8), 1027–1035.
Filardo, G., Kon, E., Longo, U. G., Madry, H., Marchettini, P., Marmotti, A., et al. (2016). Non-surgical treatments for the management of early osteoarthritis. Knee Surgery, Sports Traumatology, Arthroscopy, 24, 1775–1785.
Kraeutler, M. J., Chahla, J., LaPrade, R. F., & Pascual-Garrido, C. (2017). Biologic options for articular cartilage wear (platelet-rich plasma, stem cells, bone-marrow aspirate concentrate). Clinics in Sports Medicine, 36(3), 457–468.
Huddleston, H. P., Maheshwer, B., Wong, S. E., Chahla, J., Cole, B. J., & Yanke, A. B. (2020). An update on the use of orthobiologics: use of biologics for osteoarthritis. Operative Techniques in Sports Medicine. https://doi.org/10.1016/j.otsm.2020.150759
Jayaram, P., Ikpeama, U., Rothenberg, J. B., & Malanga, G. A. (2019). Bone-marrow-derived and adipose-derived mesenchymal stem cell therapy in primary knee osteoarthritis: a narrative review. PM&R, 11(2), 177–191.
Han, F., Wang, J., Ding, L., Hu, Y., Li, W., Yuan, Z., et al. (2020). Tissue engineering and regenerative medicine: Achievements, future, and sustainability in Asia. Frontiers in Bioengineering and Biotechnology, 8, 83. https://doi.org/10.3389/fbioe.2020.00083
Abd, R. H., Bin, R., Chew, D., Kazezian, Z., & Bull, A. M. J. (2021). Autologous protein solution: A promising solution for osteoarthritis? EFORT Open Reviews, 6(9), 716–726.
Hernigou, P., & Beaujean, F. (1993). Bone-marrow activity in the upper femoral extremity in avascular osteonecrosis. Rhum (Eng Ed), 60, 610.
Holton J., Imam M., Ward J., & Snow M. (2016). The basic science of bone-marrow aspirate concentrate in chondral injuries. Orthopedic Reviews, 8(3), 6659. https://doi.org/10.4081/or.2016.6659
Imam, M. A., Mahmoud, S. S. S., Holton, J., Abouelmaati, D., Elsherbini, Y., & Snow, M. (2017). A systematic review of the concept and clinical applications of bone-marrow aspirate concentrate in orthopaedics. SICOT-J. https://doi.org/10.1051/SICOTJ/2017007
Filardo, G., Perdisa, F., Roffi, A., Marcacci, M., & Kon, E. (2016). Stem cells in articular cartilage regeneration. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/S13018-016-0378-X
Lee, D. H., Ryu, K. J., Kim, J. W., Kang, K. C., & Choi, Y. R. (2014). Bone-marrow aspirate concentrate and platelet-rich plasma enhanced bone healing in distraction osteogenesis of the tibia. Clinical Orthopaedics and Related Research, 472, 3789–3797.
Jager, M., Jelinek, E. M., Wess, K. M., Scharfstadt, A., Jacobson, M., Kevy, S., V, et al. (2009). Bone-marrow concentrate: A novel strategy for bone defect treatment. Current stem cell research & therapy, 4(1), 34–43.
Muschler, G. F., Nitto, H., Matsukura, Y., Boehm, C., Valdevit, A., Kambic, H., et al. (2003). Spine fusion using cell matrix composites enriched in bone-marrow-derived cells. Clinical orthopaedics and related research, 407, 102.
Southworth, T. M., Naveen, N. B., Nwachukwu, B. U., Cole, B. J., & Frank, R. M. (2019). Orthobiologics for focal articular cartilage defects. Clinics in sports medicine, 38(1), 109–122. https://doi.org/10.1016/J.CSM.2018.09.001
Chahla, J., Alland, J. A., & Verma, N. N. (2018). Bone-marrow aspirate concentrate for orthopaedic use. Orthopedic nursing, 37(6), 379–381. https://doi.org/10.1097/NOR.0000000000000502
Herberts, C. A., Kwa, M. S. G., & Hermsen, H. P. H. (2011). Risk factors in the development of stem cell therapy. Journal of translational medicine, 9, 1–14.
Song, L. I. N., & Tuan, R. S. (2004). Transdifferentiation potential of human mesenchymal stem cells derived from bone-marrow. The FASEB Journal, 18(9), 980–982.
Turner, L., & Knoepfler, P. (2016). Selling stem cells in the USA: Assessing the direct-to-consumer industry. Cell Stem Cell, 19(2), 154–157.
Sullivan, S. W., Aladesuru, O. M., Ranawat, A. S., & Nwachukwu, B. U. (2021). The use of biologics to improve patient-reported outcomes in hip preservation. Journal of Hip Preservation Surgery, 8(1), 3–13.
Tsitsilianos, N., Shirazi, Z., Lu, J., & Singh, J. R. (2022). Bone-marrow aspirate injection for osteoarthritis of the hip. A pilot study. Interventional Pain Medicine, 1(4), 100163. https://doi.org/10.1016/J.INPM.2022.100163
Burnham, R., Smith, A., & Hart, D. (2021). The safety and effectiveness of bone-marrow concentrate injection for knee and hip osteoarthritis: a Canadian cohort. Regenerative Medicine, 16(7), 619–628. https://doi.org/10.2217/RME-2021-0001
Whitney, K. E., Briggs, K. K., Chamness, C., Bolia, I. K., Huard, J., Philippon, M. J., et al. (2020). Bone-marrow concentrate injection treatment improves short-term outcomes in symptomatic hip osteoarthritis patients: A pilot study. Orthopaedic Journal of Sports Medicine, 8(12), 1–7. https://doi.org/10.1177/2325967120966162
Rodriguez-Fontan, F., Piuzzi, N. S., Kraeutler, M. J., & Pascual-Garrido, C. (2018). Early clinical outcomes of intra-articular injections of bone-marrow aspirate concentrate for the treatment of early osteoarthritis of the hip and knee: A cohort study. PM and R, 10(12), 1353–1359. https://doi.org/10.1016/j.pmrj.2018.05.016
Darrow, M., Shaw, B., Darrow, B., & Wisz, S. (2018). Short-term outcomes of treatment of hip osteoarthritis with 4 bone-marrow concentrate injections: A case series. Clinical Medicine Insights: Case Reports. https://doi.org/10.1177/1179547618791574
Fortier, L. A., Potter, H. G., Rickey, E. J., Schnabel, L. V., Foo, L. F., Chong, L. R., et al. (2010). Concentrated bone-marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. JBJS, 92(10), 1927–1937.
Johnson R. G. (2014). Bone-marrow concentrate with allograft equivalent to autograft in lumbar fusions. Spine (Phila Pa 1976), 39(9), 695-700. https://doi.org/10.1097/BRS.0000000000000254.
Filardo, G., Madry, H., Jelic, M., Roffi, A., Cucchiarini, M., & Kon, E. (2013). Mesenchymal stem cells for the treatment of cartilage lesions: From preclinical findings to clinical application in orthopaedics. Knee surgery, sports traumatology, arthroscopy, 21, 1717–1729.
Hyer, C. F., Berlet, G. C., Bussewitz, B. W., Hankins, T., Ziegler, H. L., & Philbin, T. M. (2013). Quantitative assessment of the yield of osteoblastic connective tissue progenitors in bone-marrow aspirate from the iliac crest, tibia, and calcaneus. JBJS, 95(14), 1312–1316.
Marx R. E., & Tursun R. (2013). A qualitative and quantitative analysis of autologous human multipotent adult stem cells derived from three anatomic areas by marrow aspiration: tibia, anterior ilium, and posterior ilium. Int J Oral Maxillofac Implants, 28(5), e290-4. https://doi.org/10.11607/jomi.te10.
Hernigou, P. H., Poignard, A., Beaujean, F., & Rouard, H. (2005). Percutaneous autologous bone-marrow grafting for nonunions: Influence of the number and concentration of progenitor cells. JBJS, 87(7), 1430–1437.
Hernigou, J., Picard, L., Alves, A., Silvera, J., Homma, Y., & Hernigou, P. (2014). Understanding bone safety zones during bone-marrow aspiration from the iliac crest: The sector rule. International orthopaedics, 38, 2377–2384.
Hernigou, P., Homma, Y., Flouzat, L. C. H., Poignard, A., Allain, J., Chevallier, N., et al. (2013). Benefits of small volume and small syringe for bone-marrow aspirations of mesenchymal stem cells. International orthopaedics, 37, 2279–2287.
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143–147.
Themistocleous G. S., Chloros G. D., Kyrantzoulis I. M., Georgokostas I. A., Themistocleous M. S., Papagelopoulos P. J., et al. (2018). Effectiveness of a single intra-articular bone-marrow aspirate concentrate (BMAC) injection in patients with grade 3 and 4 knee osteoarthritis. Heliyon, 4(10), e00871. https://doi.org/10.1016/j.heliyon.2018.e00871.
Fortier, L. A., Strauss, E. J., Shepard, D. O., Becktell, L., & Kennedy, J. G. (2019). Biological effects of bone-marrow concentrate in knee pathologies. The journal of knee surgery, 32(01), 2–8.
Chahla, J., Dean, C. S., Moatshe, G., Pascual-Garrido, C., Serra, C. R., & LaPrade, R. F. (2016). Concentrated bone-marrow aspirate for the treatment of chondral injuries and osteoarthritis of the knee: A systematic review of outcomes. Orthopaedic journal of sports medicine, 4(1), 2325967115625481.
Shapiro, S. A., Arthurs, J. R., Heckman, M. G., Bestic, J. M., Kazmerchak, S. E., Diehl, N. N., et al. (2019). Quantitative T2 MRI mapping and 12-month follow-up in a randomized, blinded, placebo controlled trial of bone-marrow aspiration and concentration for osteoarthritis of the knees. Cartilage, 10(4), 432–443.
Shaw, B., Darrow, M., & Derian, A. (2018). Short-term outcomes in treatment of knee osteoarthritis with 4 bone-marrow concentrate injections. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 11, 1179544118781080.
Centeno, C. J., Al-Sayegh, H., Bashir, J., Goodyear, S., & Freeman, M. D. (2015). A dose response analysis of a specific bone-marrow concentrate treatment protocol for knee osteoarthritis. BMC Musculoskeletal Disorders, 16, 1–8.
Centeno C. J., Al-Sayegh H., Bashir J., Goodyear S., & Freeman M. D. (2015). A prospective multi-site registry study of a specific protocol of autologous bone-marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. Journal of Pain Research, 8, 269–276. https://doi.org/10.2147/JPR.S80872.
Darrow, M., Shaw, B., Schmidt, N., Boeger, G., & Budgett, S. (2019). Treatment of shoulder osteoarthritis and rotator cuff tears with bone-marrow concentrate and whole bone-marrow injections. Cogent Medicine, 6(1), 1628883.
Sampson, S., Smith, J., Vincent, H., Aufiero, D., Zall, M., & Botto-van-Bemden, A. (2016). Intra-articular bone-marrow concentrate injection protocol: Short-term efficacy in osteoarthritis. Regenerative medicine, 11(6), 511–520.
Centeno, C. J., Pitts, J. A., Al-Sayegh, H., & Freeman, M. D. (2014). Efficacy and safety of bone-marrow concentrate for osteoarthritis of the hip; treatment registry results for 196 patients. J Stem Cell Res Ther, 4(10), 242.
Bain, B. J. (2003). Bone-marrow biopsy morbidity and mortality. British journal of haematology, 121(6), 949–951.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No conflict of interest.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chandrashekar, S., Jeyaraman, M., Mounissamy, P. et al. Safety and Efficacy of Bone-Marrow Aspirate Concentrate in Hip Osteoarthritis: A Systematic Review of Current Clinical Evidence. JOIO (2024). https://doi.org/10.1007/s43465-024-01183-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s43465-024-01183-7